Literature DB >> 25202450

Incidence of imipenem-resistant Acinetobacter baumannii in a general intensive care unit (ICU).

Mostafa Alavi-Moghadam1, Mirmohammad Miri2, Majid Mokhtari2, Mehran Kouchek2, Reza Goharani2, Mohammad Sistanzad3, Saeed Safari1, Mehrdad Solouki4.   

Abstract

Entities:  

Year:  2014        PMID: 25202450      PMCID: PMC4143744     

Source DB:  PubMed          Journal:  Caspian J Intern Med        ISSN: 2008-6164


× No keyword cloud information.
Sir Hospital-acquired infections in critically ill patients remain one of the most important contributors to morbidity and mortality. Hospital-acquired A. baumannii has emerged as a serious threat to ICU patient population. The main purpose of our study was to determine the incidence of ICU acquired imipenem-resistant A. baumannii and its impact on ICU mortality. This prospective study was carried from January 2010 to October 2010 in a general ICU of a major teaching hospital in Tehran, Iran. The patients who had positive culture of A. baumannii were included in the study. A. baumanni isolates were tested for the sensitivity or resistance to imipenem by E-test. Each test contains 10 mcg of imipenem. Sensitivity to imipenem was defined as less than 4 mcg/ml. Sixty one positive cultures from 61 patients were detected during the study period. The most frequent infection was ventilator-associated pneumonia. Fifty (82.5 %) of isolates were detected in sputum, 5 (8%) in wounds, 3 (4.9%) in urine, 2 (3%) from central venous line and 1 (1.6) in blood. All isolates were imipenem resistant. The resistance level determined by the E-test was 12 mcg/ml in 1% of patients, 16 in 4%, 24 in 5%, and 32 in 88% of isolates. In this study, A. baumannii displayed 100% resistance to imipenem. Other study has reported imipenem resistance in the range of 11-24% (1). In a report from 5 European countries, Acinetobacter species were found to have the highest increase in resistance to antibiotics among all the gram-negative bacilli studied (2). Several risk factors have been identified for developing infection with multidrug- resistant A. baumannii, including admission diagnosis of multiple trauma, mechanical ventilation, length of ICU stay, colonization pressure within the unit and exposure to antimicrobials agents (3- 6). The alarming imipenem resistance in this study can be due to inappropriate choice of antibiotics and doses. In one large multicenter study in US hospitals, acinetobacter blood stream infection was associated with a crude mortality rate of 34% (7). The reviewed data suggest that infection with or the acquisition of A. baumannii seems to be associated with increased mortality (8). A.baumannii has been found on inanimate surfaces even after cleaning with antiseptic solutions (9). Healthcare workers play a potential role in epidemic outbreaks through the contamination of the environment and other patients. However, this very alarming study conveys important messages that strict infection control measures have to be put in place by infection control department. In summary, considering the unacceptably of the high incidence of imipenem resistant A. baumannii infections with its significant morbidity, mortality and costs, it is mandatory to improve infection control strategies and optimize its diagnosis and management.
  9 in total

1.  Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection.

Authors:  M del Mar Tomas; M Cartelle; S Pertega; A Beceiro; P Llinares; D Canle; F Molina; R Villanueva; J M Cisneros; G Bou
Journal:  Clin Microbiol Infect       Date:  2005-07       Impact factor: 8.067

2.  Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences.

Authors:  E G Playford; J C Craig; J R Iredell
Journal:  J Hosp Infect       Date:  2007-01-23       Impact factor: 3.926

3.  Investigation of an outbreak of multi-drug resistant Acinetobacter baumannii in an intensive care burns unit.

Authors:  S A Roberts; R Findlay; S D Lang
Journal:  J Hosp Infect       Date:  2001-07       Impact factor: 3.926

4.  Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study Groups.

Authors:  H Hanberger; J A Garcia-Rodriguez; M Gobernado; H Goossens; L E Nilsson; M J Struelens
Journal:  JAMA       Date:  1999-01-06       Impact factor: 56.272

5.  Investigation of a nosocomial outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a hospital setting.

Authors:  A Carbonne; T Naas; K Blanckaert; C Couzigou; C Cattoen; J-L Chagnon; P Nordmann; P Astagneau
Journal:  J Hosp Infect       Date:  2005-05       Impact factor: 3.926

6.  Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii.

Authors:  X Corbella; A Montero; M Pujol; M A Domínguez; J Ayats; M J Argerich; F Garrigosa; J Ariza; F Gudiol
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

7.  Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.

Authors:  Hilmar Wisplinghoff; Tammy Bischoff; Sandra M Tallent; Harald Seifert; Richard P Wenzel; Michael B Edmond
Journal:  Clin Infect Dis       Date:  2004-07-15       Impact factor: 9.079

8.  Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study.

Authors:  Sang-Oh Lee; Nam Joong Kim; Sang-Ho Choi; Tae Hyong Kim; Jin-Won Chung; Jun-Hee Woo; Jiso Ryu; Yang Soo Kim
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

Review 9.  Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies.

Authors:  Matthew E Falagas; Ioannis A Bliziotis; Ilias I Siempos
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

  9 in total
  2 in total

1.  The effect of the efflux pump inhibitor Carbonyl Cyanide m-Chlorophenylhydrazone (CCCP) on the susceptibility to imipenem and cefepime in clinical strains of Acinetobacter baumannii.

Authors:  Alejandra Sanchez-Carbonel; Belén Mondragón; Nicolás López-Chegne; Isaac Peña-Tuesta; Gladys Huayan-Dávila; Dora Blitchtein; Hugo Carrillo-Ng; Wilmer Silva-Caso; Miguel Angel Aguilar-Luis; Juana Del Valle-Mendoza
Journal:  PLoS One       Date:  2021-12-17       Impact factor: 3.240

2.  Antimicrobial Resistance of Acinetobacter baumannii to Imipenem in Iran: A Systematic Review and Meta-Analysis.

Authors:  Maryam Pourhajibagher; Farhad B Hashemi; Babak Pourakbari; Masoud Aziemzadeh; Abbas Bahador
Journal:  Open Microbiol J       Date:  2016-03-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.